Subscribe to RSS Feed
Medicines-Diabetes Treatment-TechnoMedService-InstituteOfEPM-Edas-Boiron-Bionorica-Ozon-Ferring-EndoPharm-NovoNordisk-Teva-GSK-Kanonfarma-Merck Sharp & Dohme-LeoLab-Pabianice-Pharmstandart-NorthStar-Madaus-EGIS-Sandoz-PierreFabre-Kamelia-Ultratab-Meda-Biosintez-Scan Biotech-Pliva-Hyperion-HiGlance-Vermodje-Elamad
Ozempic® (Semavik) 0,25/0,5/1 mg/dose solution for subcutaneous administration 3 ml syringe pen 1 pc.
Ozempic is a self-injectable medication that contains the active ingredient, semaglutide. Previously, it has been prescribed ‘off label’ for weight loss, but it is licensed in the UK for treating type 2 diabetes. Semaglutide is available as a weight loss injection under the brand name Semavik.
Medicines-Diabetes Treatment-TechnoMedService-InstituteOfEPM-Edas-Boiron-Bionorica-Ozon-Ferring-EndoPharm-NovoNordisk-Teva-GSK-Kanonfarma-Merck Sharp & Dohme-LeoLab-Pabianice-Pharmstandart-NorthStar-Madaus-EGIS-Sandoz-PierreFabre-Kamelia-Ultratab-Meda-Biosintez-Scan Biotech-Pliva-Hyperion-HiGlance-Vermodje-Elamad
Currently Shopping by
- The purpose of the medication: Remove This Item Diabetes Treatment
-
Manufacturer:
TechnoMedService
InstituteOfEPM
Edas
Boiron
Bionorica
Ozon
Ferring
EndoPharm
NovoNordisk
Teva
GSK
Kanonfarma
Merck Sharp & Dohme
LeoLab
Pabianice
Pharmstandart
NorthStar
Madaus
EGIS
Sandoz
PierreFabre
Kamelia
Ultratab
Meda
Biosintez
Scan Biotech
Pliva
Hyperion
HiGlance
Vermodje
Elamad
- The purpose of the medication
- Manufacturer
